𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Multiple sclerosis risk in radiologically uncovered asymptomatic possible inflammatory-demyelinating disease

✍ Scribed by Siva, A; Saip, S; Altintas, A; Jacob, A; Keegan, B.; Kantarci, O.

Book ID
124082100
Publisher
SAGE Publications
Year
2009
Tongue
English
Weight
475 KB
Volume
15
Category
Article
ISSN
1352-4585

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[Current Topics in Microbiology and Immu
[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease
✍ Scarisbrick, I. A. (author) 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 230 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people

[Current Topics in Microbiology and Immu
[Current Topics in Microbiology and Immunology] Advances in multiple Sclerosis and Experimental Demyelinating Diseases Volume 318 || The Multiple Sclerosis Degradome: Enzymatic Cascades in Development and Progression of Central Nervous System Inflammatory Disease
✍ Scarisbrick, I. A. (author) 📂 Article 📅 2008 🏛 Springer Berlin Heidelberg 🌐 German ⚖ 230 KB

Controversy still exists regarding how early disease-modifying agents (DMA) should be commenced and whether all patients with relapsing-remitting MS should in fact be treated. To answer these questions, it is also important to know the natural history of the disease. MS affects nearly 400,000 people